AI-generated summary
The authors retrospectively followed 16 patients with refractory discoid lupus erythematosus treated with pulsed dye laser or intense pulsed light at low fluences. They report that 14 patients improved in itching, erythema, scaling, scarring and pain, and that no scarring occurred as a side effect. The authors conclude the treatment is safe as an adjunct to conventional therapy.
- Participants
- 16
- Who or what was studied
- Sixteen patients (two men, fourteen women, aged 28-69 years, mean age 54) with histologically confirmed refractory discoid lupus erythematosus treated at university hospitals in Örebro and Malmö, Sweden.
- Limits stated in the abstract
- The study is a retrospective, small case series with no control group and long-term follow-up details are not described in the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.